Brevicon 28-day
Drug - Brevicon 28-day
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL-28
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Ethinyl Estradiol; Norethindrone
Multiple ingredients are in alphabetical order.
Strength -
0.035MG;0.5MG
The potency of the active ingredient(s), Ethinyl Estradiol; Norethindrone. May repeat for multiple part products.
Applicant -
WATSON LABS
The firm name holding legal responsibility for Brevicon 28-day. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
017743
The FDA assigned number to Brevicon 28-day. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Brevicon 28-day. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Brevicon 28-day was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Brevicon 28-day. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Brevicon 28-day is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Brevicon 28-day.
Brevicon 28-day
Ovcon-35 0.035mg;0.4mg Tablet; Oral-21 Ovcon-50 0.05mg;1mg Tablet; Oral-21 Tri-norinyl 21-day 0.035mg,0.035mg,0.035mg;0.5mg,1mg,0.5mg Tablet; Oral-21 Aranelle 0.035mg,0.035mg,0.035mg;0.5mg,1mg,0.5mg Tablet; Oral-28 Balziva-28 0.035mg;0.4mg Tablet; Oral-28 Brevicon 28-day 0.035mg;0.5mg Tablet; Oral-28 Ortho-novum 1/35-21 0.035mg;1mg Tablet; Oral-21 Ortho-novum 10/11-21 0.035mg,0.035mg;0.5mg,1mg Tablet; Oral-21 Ortho-novum 7/14-21 0.035mg,0.035mg;0.5mg,1mg Tablet; Oral-21 Ortho-novum 7/7/7-21 0.035mg,0.035mg,0.035mg;0.5mg,0.75mg,1mg Tablet; Oral-21
NewDrugInformation
|
|